AstraZeneca
1.493,5 SEK +1,05 %1 investor følger denne virksomhed
AstraZeneca is a global biopharmaceutical company that focuses on the research, development, and marketing of prescription drugs, primarily for the treatment of diseases in the areas of therapy that affect the respiratory tract, cardiovascular / metabolism, and cancer. In addition to its main operations, the company is also active in autoimmunity, neuroscience, and infection. AstraZeneca is active in all global regions and is headquartered in Cambridge.
Omsætning
462,83 mia.
EBIT %
8,47 %
P/E
67,51
Udbytteafkast, %
2,03 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
AZN
Daglig lav / høj pris
1.480,5 / 1.505
SEK
Markedsværdi
2,31 bio. SEK
Aktieomsætning
358,15 mio. SEK
Volumen
240 t
Finanskalender
Delårsrapport
09.11.2023
Årsrapport
08.02.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| BlackRock, Inc. | 6,5 % | 6,5 % |
| Wellington Management Group | 4,2 % | 4,2 % |
Premium
Not activated
This content is for our Premium customers only.
Viser Alle indholdstyper